http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103980279-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D475-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103980279-B |
| titleOfInvention | A kind of methotrexate compound and methotrexate for injection |
| abstract | The present invention relates to field of medicine preparations, disclose methotrexate compound and compositions thereof shown in a kind of formula (I), described methotrexate compound powder X-ray diffraction algoscopy measures, and demonstrates characteristic diffraction peak with the X-ray powder diffraction pattern that 2 θ ± 0.2 angles of diffraction represent at 5.81 °, 8.65 °, 11.08 °, 12.70 °, 15.14 °, 18.65 °, 20.27 °, 21.89 °, 24.32 °, 28.38 °, 30.27 ° and 32.43 ° of places.Methotrexate compound stability provided by the invention is significantly improved, quality controllable, and long-time placement is not susceptible to change, substantially increases patient medication safety； |
| priorityDate | 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.